Präklinisches Magnetic Particle Imaging | Bruker

MPI, a 3D imaging method, identifies iron-oxide nanoparticles in the bloodstream via their magnetic properties. Initially introduced by Philips in 2005, it sparked high hopes for biological imaging's future. Bruker, leveraging its innovation prowess and drive, has now made these once-envisioned possibilities a reality for the imaging community.

• Advanced 7-channel magnet system: Drive, selection, and focus field technologies
• Max acquisition rate: Up to 46 volumes per second
• ParaVision platform: Acquisition, processing, DICOM export/import
• Simplified data acquisition: One-click reconstruction
• Flexible sequence design: Customizable imaging protocols
• Complete data access: All raw data available
• Bolus injection triggering: Seamless integration with ParaVision
• Spacious imaging bore: 12 cm free access for various small animals
• Versatile animal handling: Bruker's multi-modality system
• Coil inserts: 1D Rx only for targeted imaging
• Spatial selectivity: Focused Field Projection (FFP) technology
• Theranostic capabilities: In situ theranostic insert for combined therapy and diagnosis